Atlas Trials

Rotating Pazopanib and Everolimus to Avoid Resistance

Clinical trial NCT01408004 · COMPLETED

Trial details

NCT number
NCT01408004
Sponsor
Netherlands Working Group on Immunotherapy of Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Clear Cell Renal Carcinoma
Start date
2011-11-01
Primary completion
2014-04-01
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.